Engineered Pathogens And Stealth Viruses

June 29, 2020

There is something very disturbing about vaccine development regarding the Corona virus.
One of the key firms that has been given a contract to develop vaccines against the virus, Moderna Therapeutics, has partnered with a major intelligence agency-driven box of magic tricks to develop a cure.
In “The Pentagon’s Brain – An Uncensored History of DARPA, America’s Top Secret Military Research Agency”, author Annie Jacobsen has written a 500-page expose’ of how the Pentagon and other agencies conduct top secret research that is way ahead of our time.

I have yet to read the entire book, but I went to the section on viruses to get a heads-up on what might be going on.

As will be shown, DARPA has been working on biological weapons for years. In the light of the origins of the Corona Virus, and the number of Bio-safety labs around the world that are working on viruses, we need to look at this.

Here are some very disturbing quotes about viral weapons from “The Pentagon’s Brain”:

p 297

Genetically engineered pathogens:
“It seems likely that such weapons will eventually come to exist, simply because of the lamentable ease with which they may be constructed.” They were cheap, easy to make, and, if you knew what you were looking for and could find out how to make them, freely available in the public domain.”
If you were to mix Ebola with the communicability of measles to create a pathogen that would continue to alter itself in such a way to evade treatment.”

p 298-299

The creation of Stealth Viruses:
“.. to produce a tightly regulated, cryptic viral infection, using a vector that can enter and spread in human cells, remaining resident for lengthy periods without detectable harm … a silent viral load.”

“Similarly, an unwitting population could be “slowly pre-infected with a stealth virus over an extended period, possibly years, and then synchronously triggered”

First, the case has been made that any advanced lab can obtain the tools to build a virus on the open market.
Second, the above quote suggests labs are working to achieve a “Gain of Function” status in virus research. This means to make it more transmissible and deadly.

Third, it suggests that a stealth virus could be inserted in an inoculation and be activated at some future date, perhaps years later.

That is very troubling considering what you will read next, the use of nano technology in new vaccines, something that has never been used publicly.


Beyond biological treatments:

DARPA, the Pentagon secret box-of-tricks agency is partnering with Moderna Therapeutics to use nano-technology to change human DNA and RNA to create a cellular-level machine response to the corona virus. What else it may do is unknown.

Moderna, who has partnered with DARPA for millions of dollars, has some issues:

“Moderna just moved its first two potential treatments — both vaccines — into human trials. In keeping with the culture of secrecy, though, executives won’t say which diseases the vaccines target, and they have not listed the studies on the public federal registry, Listing is optional for Phase 1 trials, which are meant to determine if a drug is safe, but most companies voluntarily disclose their work.”

And Moderna has critics in every corner:

“It’s a case of the emperor’s new clothes,” said a former Moderna scientist. “They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”


Here’s part of the problem; DARPA and Moderna want to alter human DNA to turn the human body into a cellular-level machine to combat the virus. What else it does is not clear, let alone long-term side effects of this technology:

“Since the early 2010s, DARPA has invested in a new type of vaccine technology — nucleic acid vaccines — which use the human body as its “bioreactor” to create the antibodies needed for immunity. DARPA funded this type of vaccine because traditional vaccine manufacturing is cumbersome, Jenkins said, and can take up to 18 months.

DARPA’s efforts on new mRNA vaccines have perhaps led to the best chance of effective immunization against COVID-19. This is in part thanks to a $25 million grant it awarded in 2013 to biotech company Moderna to manufacture mRNA vaccines to protect against a “wide range of known and unknown emerging infectious diseases and engineered biological threats.”

Now, a Moderna mRNA vaccine for COVID-19 is undergoing a clinical trial with the NIH. DARPA leaders are confident it will be deemed safe “because of some of our past investments that we’ve done on similar products for different diseases,” Ringeisen said”

Please note – turn the human body into a “bioreactor”.
That means to change human DNA.

Additionally, they have an epigenitics feature that will take in all of the subject’s physical history:

“DARPA hypothesized years ago that infectious diseases left “epigenetic marks” on human cells, or chemical changes in cells that indicate exposure to toxins, much like epigenetic marks left in smokers.”

Your entire history.

Additionally, Moderna has had issues with their products:

“Earlier this year, Moderna ran into a speed bump while working on combining two vaccines for cytomegalovirus, or CMV, according to the company’s securities filings. Moderna was running an early-stage trial when it realized in August one of the vaccines “did not meet our internal quality control specifications for visual inspection after one year of storage.” The FDA placed a clinical hold on the trial and Moderna agreed to remove that vaccine from the study.”


Now we need to look at the origins of the virus. Here is an analysis from a retired Navy expert on modern warfare:

“Francis Boyle is a professor of international law at the University of Illinois. He has served on the Advisory Board for the Council for Responsible Genetics and drafted the U.S. legislation for the Biological Weapons Anti-Terrorism Act of 1989. He believes a “smoking gun,” proving that the coronavirus came from bioweapons research, is contained in a February 10, 2020 genetic analysis titled “Coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.”

The study, Published on ScienceDirect in March 2020, identified a “gain-of-function to the 2019-nCoV for efficient spreading in the human population compared to other coronaviruses.” As an expert in bioweapons research and terminology, Boyle said “Gain of function technology is DNA genetic engineering of a dangerous biological warfare substance, but turbocharging and gain of function work can only be done safely in a BSL-4 or a BSL-3 facility.”


And finally we finish with a past post about the manipulation of the Corona Virus in a university lab in 2015:

“Lab-Made Coronavirus Triggers Debate

“The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research”

“Ralph Baric, an infectious-disease researcher at the University of North Carolina at Chapel Hill, last week (November 9) published a study on his team’s efforts to engineer a virus with the surface protein of the SHC014 coronavirus, found in horseshoe bats in China, and the backbone of one that causes human-like severe acute respiratory syndrome (SARS) in mice. The hybrid virus could infect human airway cells and caused disease in mice, according to the team’s results, which were published in Nature Medicine.”


“They also reignite a debate about whether that information justifies the risk of such work, known as gain-of-function research. “If the [new] virus escaped, nobody could predict the trajectory,” Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, told Nature.”


“In October 2013, the US government put a stop to all federal funding for gain-of-function studies, with particular concern rising about influenza, SARS, and Middle East respiratory syndrome (MERS).”


“The debate comes down to how informative the results are. “The only impact of this work is the creation, in a lab, of a new, non-natural risk,” Richard Ebright, a molecular biologist and biodefence expert at Rutgers University, told Nature.”


No way to tell where this is going yet.
A real vaccine takes years of safety tests to be approved. That is not happening.
Add the fact that this Moderna-DARPA project is post-biological, nano-technology designed to change human DNA, is very disturbing to say the least.

Share Button

Tags: , , , ,

One Response to Engineered Pathogens And Stealth Viruses

  1. Tex on July 6, 2020 at 2:37 pm

    We should all be extremely leery of any claims that a vaccine will magically appear in little less than a fortnight. Virtually all of the credible sources I have found suggest that the development of an effective vaccine for the COVID-19 or any other communicable pathogen is almost certain to take years, as in at least 2-3 years and possible as long as 5 years or more.

    Fauci himself has acknowledged that the development of a vaccine is likely to take 2-3 years and possible even longer than that.

    If an effective vaccine were to appear on the market in less than a couple of years it would be de facto evidence that some of these labs have actually been working on a COVID-19 vaccine for many years, probably since the 2002-03 outbreak of the SARS virus in Japan, which is another corona virus that is similar in some respects to the novel virus known as COVID-19.

    “Government is complex, far too complex for anything to happen by accident.” – John Stockwell

Leave a Reply

Your email address will not be published. Required fields are marked *

85 + = ninety four